Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?
Märtson AG, Sturkenboom MGG, Stojanova J, Cattaneo D, Hope W, Marriott D, Patanwala AE, Peloquin CA, Wicha SG, van der Werf TS, Tängdén T, Roberts JA, Neely MN, Alffenaar JC. Märtson AG, et al. Among authors: van der werf ts. Clin Microbiol Infect. 2020 Aug;26(8):1008-1016. doi: 10.1016/j.cmi.2020.03.008. Epub 2020 Mar 21. Clin Microbiol Infect. 2020. PMID: 32205294 Free article. Review.
Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis.
Dijkstra JA, van Altena R, Akkerman OW, de Lange WC, Proost JH, van der Werf TS, Kosterink JG, Alffenaar JW. Dijkstra JA, et al. Among authors: van altena r, van der werf ts. Int J Antimicrob Agents. 2015 Sep;46(3):332-7. doi: 10.1016/j.ijantimicag.2015.06.008. Epub 2015 Jul 15. Int J Antimicrob Agents. 2015. PMID: 26228464
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.
van Altena R, Dijkstra JA, van der Meer ME, Borjas Howard JF, Kosterink JG, van Soolingen D, van der Werf TS, Alffenaar JW. van Altena R, et al. Among authors: van der werf ts, van soolingen d, van der meer me. Antimicrob Agents Chemother. 2017 Feb 23;61(3):e01400-16. doi: 10.1128/AAC.01400-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 28069654 Free PMC article.
Ganciclovir Therapeutic Drug Monitoring: A Case Series.
Märtson AG, Touw D, Damman K, Bakker M, Oude Lansink-Hartgring A, van der Werf T, Knoester M, Alffenaar JC. Märtson AG, et al. Ther Drug Monit. 2019 Apr;41(2):107-110. doi: 10.1097/FTD.0000000000000598. Ther Drug Monit. 2019. PMID: 30883503 Free PMC article.
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.
Boonstra JM, Märtson AG, Sandaradura I, Kosterink JGW, van der Werf TS, Marriott DJE, Zijlstra JG, Touw DJ, Alffenaar JWC. Boonstra JM, et al. Among authors: van der werf ts. Antimicrob Agents Chemother. 2021 Feb 17;65(3):e01554-20. doi: 10.1128/AAC.01554-20. Print 2021 Feb 17. Antimicrob Agents Chemother. 2021. PMID: 33361296 Free PMC article.
Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?".
Märtson AG, Boonstra JM, Sandaradura I, Kosterink JGW, van der Werf TS, Marriott DJE, Zijlstra JG, Touw DJ, Alffenaar JWC. Märtson AG, et al. Among authors: van der werf ts. Antimicrob Agents Chemother. 2021 May 18;65(6):e00465-21. doi: 10.1128/AAC.00465-21. Print 2021 May 18. Antimicrob Agents Chemother. 2021. PMID: 33782002 Free PMC article. No abstract available.
Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads.
Märtson AG, Sturkenboom MGG, Knoester M, van der Werf TS, Alffenaar JC, Hope W; GATEWAY-1 Study Consortium. Märtson AG, et al. Among authors: van der werf ts. J Antimicrob Chemother. 2022 Feb 2;77(2):466-473. doi: 10.1093/jac/dkab419. J Antimicrob Chemother. 2022. PMID: 35107143 Free PMC article.
392 results